Answers are grounded in this paper and cite their sources.
To develop a highly sensitive and interference-resistant ultra performance liquid chromatography (UPLC) coupled with high-resolution selected ion monitoring (HR-SIM) mass spectrometry method for the quantification of semaglutide in biological samples, and to apply it for pharmacokinetic analysis. The UPLC-HR-SIM method was utilized to quantify semaglutide in beagle plasma, requiring minimal sample pretreatment. The method demonstrated a lower limit of quantification (LLOQ) of 5.0 ng/mL for semaglutide in beagle plasma. Following intravenous (iv) administration at a dose of 0.030 mg/kg, the plasma concentration of semaglutide in beagles exhibited a multi-exponential decay pattern, with an average elimination half-life (t 1/2 ) of 44.90 ± 11.45 h. The UPLC-HR-SIM method has proven to be a highly sensitive and robust approach for the quantification of peptide-based drugs. This method will enhance the understanding of the pharmacokinetics and pharmacodynamics of semaglutide and facilitate further research into the pharmacokinetics of other peptide therapeutics. • A highly sensitive and universal method for the quantitation of peptide drugs. • This method has been fully validated for semaglutide quantifying. • Pharmacokinetic parameters of somaglutide in the plasma of beagles.
No takes yet. Share an insight, caveat, or question.
Xinyi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: